BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32436006)

  • 1. Clusters in Pediatric Rheumatic Diseases.
    Sag E; Demir S; Ozen S
    Curr Rheumatol Rep; 2020 May; 22(7):28. PubMed ID: 32436006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
    Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
    Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
    Pinto B; Deo P; Sharma S; Syal A; Sharma A
    Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
    Grim A; Veiga KR; Saad N
    Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of adenosine deaminase 2 (DADA2): Review.
    Sharma V; Deo P; Sharma A
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases.
    Fayand A; Chasset F; Boutboul D; Queyrel V; Tieulié N; Guichard I; Dupin N; Franck N; Cohen P; Bessis D; Guenno GL; Koné-Paut I; Belot A; Bonhomme A; Ducharme-Bénard S; Grateau G; Sarrabay G; Touitou I; Boursier G; Georgin-Lavialle S
    Semin Arthritis Rheum; 2021 Dec; 51(6):1170-1179. PubMed ID: 34571400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
    Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Aksentijevich I; Zhou Q
    Semin Immunopathol; 2022 May; 44(3):269-280. PubMed ID: 35178658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
    Chen L; Mamutova A; Kozlova A; Latysheva E; Evgeny F; Latysheva T; Savostyanov K; Pushkov A; Zhanin I; Raykina E; Kurnikova M; Mersiyanova I; Platt CD; Jee H; Brodeur K; Du Y; Liu M; Weiss A; Schulert GS; Rodriguez-Smith J; Hershfield MS; Aksentijevich I; Zhou Q; Nigrovic PA; Shcherbina A; Alexeeva E; Lee PY
    J Allergy Clin Immunol; 2023 Sep; 152(3):771-782. PubMed ID: 37150360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
    Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
    Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
    Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
    Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
    Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
    Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S
    Front Immunol; 2022; 13():869570. PubMed ID: 35592317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset stroke and vasculopathy associated with mutations in ADA2.
    Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
    N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset deficiency of adenosine deaminase 2-a case report and literature review.
    Zhang B; Sun Y; Xu N; Wang W; Huang X; Chen J; Shen M; Wang R; Zeng X; Zhang X
    Clin Rheumatol; 2021 Oct; 40(10):4325-4339. PubMed ID: 33638065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.